Hide metadata

dc.date.accessioned2023-03-08T18:05:42Z
dc.date.available2023-03-08T18:05:42Z
dc.date.created2023-02-16T08:39:41Z
dc.date.issued2023
dc.identifier.citationHatlem, Daniel Christensen, Mikkel Broeker, Nina Kristiansen, Per Eugen Lund, Reidar Barbirz, Stefanie Linke, Dirk . A trimeric coiled-coil motif binds bacterial lipopolysaccharides with picomolar affinity. Frontiers in Cellular and Infection Microbiology. 2023, 13
dc.identifier.urihttp://hdl.handle.net/10852/101056
dc.description.abstractα-helical coiled-coils are ubiquitous protein structures in all living organisms. For decades, modified coiled-coils sequences have been used in biotechnology, vaccine development, and biochemical research to induce protein oligomerization, and form self-assembled protein scaffolds. A prominent model for the versatility of coiled-coil sequences is a peptide derived from the yeast transcription factor, GCN4. In this work, we show that its trimeric variant, GCN4-pII, binds bacterial lipopolysaccharides (LPS) from different bacterial species with picomolar affinity. LPS molecules are highly immunogenic, toxic glycolipids that comprise the outer leaflet of the outer membrane of Gram-negative bacteria. Using scattering techniques and electron microscopy, we show how GCN4-pII breaks down LPS micelles in solution. Our findings suggest that the GCN4-pII peptide and derivatives thereof could be used for novel LPS detection and removal solutions with high relevance to the production and quality control of biopharmaceuticals and other biomedical products, where even minuscule amounts of residual LPS can be lethal.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleA trimeric coiled-coil motif binds bacterial lipopolysaccharides with picomolar affinity
dc.title.alternativeENEngelskEnglishA trimeric coiled-coil motif binds bacterial lipopolysaccharides with picomolar affinity
dc.typeJournal article
dc.creator.authorHatlem, Daniel
dc.creator.authorChristensen, Mikkel
dc.creator.authorBroeker, Nina
dc.creator.authorKristiansen, Per Eugen
dc.creator.authorLund, Reidar
dc.creator.authorBarbirz, Stefanie
dc.creator.authorLinke, Dirk
cristin.unitcode185,15,29,40
cristin.unitnameSeksjon for biokjemi og molekylærbiologi
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2126504
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Frontiers in Cellular and Infection Microbiology&rft.volume=13&rft.spage=&rft.date=2023
dc.identifier.jtitleFrontiers in Cellular and Infection Microbiology
dc.identifier.volume13
dc.identifier.doihttps://doi.org/10.3389/fcimb.2023.1125482
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn2235-2988
dc.type.versionPublishedVersion
cristin.articleid1125482
dc.relation.projectNFR/240483
dc.relation.projectNFR/267434
dc.relation.projectOTHER/Innovation Funding / Inven2


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International